These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31684820)

  • 1. A simple method to identify undiagnosed drug-induced liver injury (DILI) and its application in oncology pharmacy practice.
    Wen H; Ge M; Yao D; Liu L
    J Oncol Pharm Pract; 2020 Jul; 26(5):1060-1069. PubMed ID: 31684820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of liver injury among cancer patients receiving chemotherapy in an integrated health system.
    Ulcickas Yood M; Bortolini M; Casso D; Beck JG; Oliveria SA; Wells KE; Woodcroft KJ; Wang LI
    Pharmacoepidemiol Drug Saf; 2015 Apr; 24(4):427-34. PubMed ID: 25683797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.
    Lo Re V; Haynes K; Forde KA; Goldberg DS; Lewis JD; Carbonari DM; Leidl KB; Reddy KR; Nezamzadeh MS; Roy J; Sha D; Marks AR; De Boer J; Schneider JL; Strom BL; Corley DA
    Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2360-8. PubMed ID: 26122767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
    Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
    Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tuberculosis drug-induced liver injury in Shanghai: validation of Hy's Law.
    Shen X; Yuan Z; Mei J; Zhang Z; Guo J; Wu Z; Wu J; Zhang H; Pan J; Huang W; Gong H; Yuan D; Xiao P; Wang Y; Shuai Y; Lin S; Pan Q; Zhou T; Watkins PB; Wu F
    Drug Saf; 2014 Jan; 37(1):43-51. PubMed ID: 24203912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.
    Shen T; Liu Y; Shang J; Xie Q; Li J; Yan M; Xu J; Niu J; Liu J; Watkins PB; Aithal GP; Andrade RJ; Dou X; Yao L; Lv F; Wang Q; Li Y; Zhou X; Zhang Y; Zong P; Wan B; Zou Z; Yang D; Nie Y; Li D; Wang Y; Han X; Zhuang H; Mao Y; Chen C
    Gastroenterology; 2019 Jun; 156(8):2230-2241.e11. PubMed ID: 30742832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study to evaluate Hy's Law, DrILTox ALF score, Robles-Diaz model, and a new logistic regression model for predicting acute liver failure in Chinese patients with drug-induced liver injury.
    Xiong X; Xu Q; Wang B
    Expert Opin Drug Saf; 2024 Feb; 23(2):207-211. PubMed ID: 36958375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of multivariate outlier detection analyses used to identify potential drug-induced liver injury in clinical trial populations.
    Lin X; Parks D; Painter J; Hunt CM; Stirnadel-Farrant HA; Cheng J; Menius A; Lee K
    Drug Saf; 2012 Oct; 35(10):865-75. PubMed ID: 22928730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico modeling to optimize interpretation of liver safety biomarkers in clinical trials.
    Church RJ; Watkins PB
    Exp Biol Med (Maywood); 2018 Feb; 243(3):300-307. PubMed ID: 29096561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical data.
    Parks D; Lin X; Painter JL; Cheng J; Hunt CM; Spraggs CF; Nelson JJ; Curtis L; Menius JA; Lee KR
    Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):571-8. PubMed ID: 23300062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death and liver transplantation within 2 years of onset of drug-induced liver injury.
    Hayashi PH; Rockey DC; Fontana RJ; Tillmann HL; Kaplowitz N; Barnhart HX; Gu J; Chalasani NP; Reddy KR; Sherker AH; Hoofnagle JH;
    Hepatology; 2017 Oct; 66(4):1275-1285. PubMed ID: 28543844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of drug-induced liver injury in early-phase oncology clinical trials.
    Mondaca SP; Liu D; Flynn JR; Badson S; Hamaway S; Gounder MM; Khalil DN; Drilon AE; Li BT; Jhaveri KL; Schram AM; Kargus KE; Kasler MK; Blauvelt NM; Segal NH; Capanu M; Callahan MK; Hyman DM; Gambarin-Gelwan M; Harding JJ
    Cancer; 2020 Nov; 126(22):4967-4974. PubMed ID: 32809222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to avoid being surprised by hepatotoxicity at the final stages of drug development and approval.
    Regev A
    Clin Liver Dis; 2013 Nov; 17(4):749-67, xi. PubMed ID: 24099029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-induced liver injury (DILI)].
    Benesic A
    MMW Fortschr Med; 2019 May; 161(8):57-62. PubMed ID: 31037662
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-Induced Liver Injury Is a Major Risk for New Drugs.
    Seeff LB
    Dig Dis; 2015; 33(4):458-63. PubMed ID: 26159259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Art and Science of Diagnosing and Managing Drug-induced Liver Injury in 2015 and Beyond.
    Lewis JH
    Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2173-89.e8. PubMed ID: 26116527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced liver injury in children: A nationwide cohort study from China.
    Lai R; Li X; Zhang J; Chen J; Yang C; Xie W; Yu Y; Guo X; Zhang X; Lu G; Han X; Xie Q; Chen C; Shen T; Mao Y;
    JHEP Rep; 2024 Aug; 6(8):101102. PubMed ID: 39105181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-Induced Liver Injury from Anti-Tuberculosis Treatment: A Retrospective Cohort Study.
    Zhao H; Wang Y; Zhang T; Wang Q; Xie W
    Med Sci Monit; 2020 Mar; 26():e920350. PubMed ID: 32145061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Hepatic Impairment on Outcomes in Phase I Clinical Trials in Cancer Subjects.
    Mansfield AS; Rudek MA; Vulih D; Smith GL; Harris PJ; Ivy SP;
    Clin Cancer Res; 2016 Nov; 22(22):5472-5479. PubMed ID: 27189163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective nationwide study of drug-induced liver injury in Korea.
    Suk KT; Kim DJ; Kim CH; Park SH; Yoon JH; Kim YS; Baik GH; Kim JB; Kweon YO; Kim BI; Kim SH; Kim IH; Kim JH; Nam SW; Paik YH; Suh JI; Sohn JH; Ahn BM; Um SH; Lee HJ; Cho M; Jang MK; Choi SK; Hwang SG; Sung HT; Choi JY; Han KH
    Am J Gastroenterol; 2012 Sep; 107(9):1380-7. PubMed ID: 22733303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.